Governance

The team and organisations behind IRONMAN

Governance, hero banner

IRONMAN is governed by an Executive Committee, a Scientific Advisory Committee and the Global Clinical & Data Coordination Center (CDCC), and have also established a Diversity Working Group.

About the Executive Committee

The Executive Committee independently governs the project direction, clinical and financial management, and also ensures the objectives and vision of the IRONMAN Registry are met. Registry reports and publications will be managed by the Executive Committee with input from the Scientific Advisory Committee.

Lorelei Mucci, ScD, MPH

Professor of Epidemiology

Harvard TH Chan School of Public Health

Daniel George, MD

Professor of Medicine, Director of Genitourinary Oncology

Duke Cancer Institute

Philip Kantoff, MD

CEO and co-Founder, Convergent Therapeutics

Memorial Sloan Kettering Cancer Center

Jake Vinson

Chief Executive Officer

Prostate Cancer Clinical Trials Consortium

Paul Villanti

Executive Director, Programs

Movember Foundation

About the Scientific Advisory Committee

The Scientific Advisory Committee will consist of representatives from country lead participating sites, Funding Companies (non-voting members) and the advocacy community. They will evaluate the accumulated study data and make recommendations to Executive Committee concerning the IRONMAN Registry.

Ian Davis, MBBS(Hons), PhD, FRACP, FAChPM, FAHMS, GAICD

Professor of Medicine

Monash University and Eastern Health

Professor Sue Evans, PhD

Head of Clinical Registry Unit

Monash University

Andre Fay, MD

Professor of Medicine

Pontifícia Universidade Católica do Rio Grande do Sul

Raymond McDermott, MD, PhD, MBA

Medical Oncologist

St. Vincent's University Hospital

Anders Bjartell, MD, PhD, FEBU

Professor or Urology

Skåne University Hospital, Malmö, Sweden

Aurelius Omlin, MD

Medical Oncologist

Kantonsspital, St. Gallen

Professor Silke Gillessen

Professor of Medicine

Kantonsspital, St. Gallen

Deborah Enting, MD

Consultant Medical Oncologist

Guy's and St Thomas' NHS Foundation Trust

Daniel George, MD

Professor of Medicine and Director of Genitourinary Oncology

Duke University

Philip Kantoff, MD

CEO and co-Founder, Convergent Therapeutics

Memorial Sloan Kettering Cancer Center

Lorelei Mucci, ScD, MPH

Professor of Epidemiology

Harvard TH Chan School of Public Health

Stacey Simmons, MD

Senior Medical Director Breast and Ovarian Cancer

Novartis

Joseph Germino, MD

Vice President Of Medican Affairs, Oncology

Bayer

Sarah Payne, MBBS, PhD, FRCP

Global Medical Affairs

AstraZeneca

Ted Szatrowski

Senior Medical Director, Oncology

Sanofi

Kim Chi, MD, FRCP(C)

Chief Medical Officer

BC Cancer

Ademola Popoola, MBBS, FMCS, FWACS

Associate Professor of Urology Surgery, Consultant Urologist

University of Ilorin

Global Clinical & Data Coordination Center (CDCC)

The Prostate Cancer Clinical Trials Consortium (PCCTC) is the Global Clinical and Data Coordination Center for the IRONMAN Registry. The PCCTC provides project management, contracting, regulatory supervision, site management in the U.S., data management and quality assurance for the entire Registry, and data monitoring according to this protocol and any individual funding partner agreements.

Jake Vinson

Chief Executive Officer

Prostate Cancer Clinical Trials Consortium

Rebecca Green

Director, Clinical Strategy & Operations

Prostate Cancer Clinical Trials Consortium

Amanda McMannis

Associate Director, Clinical Operations

Prostate Cancer Clinical Trials Consortium

Marie Grant

Project Manager

Prostate Cancer Clinical Trials Consortium

Joy Allen

Director, Clinical Data Management & Informatics

Prostate Cancer Clinical Trials Consortium

Alyssa Chan-Cuzydlo

Senior Clinical Data Manager

Prostate Cancer Clinical Trials Consortium

Alfie Previti

Assistant Clinical Data Manager

Prostate Cancer Clinical Trials Consortium

Lina Patel

Project Associate

Prostate Cancer Clinical Trials Consortium

Nicole Riga

Project Associate

Prostate Cancer Clinical Trials Consortium

Laurel Cannon

Project Manager

Prostate Cancer Clinical Trials Consortium

Diversity Working Group

Franklin Huang, MD, PhD

Associate Professor Department of Medicine

University of California, San Francisco

Elisabeth Heath, MD, FACPP

Medical Oncologist, Center Director for Translational Sciences

Karmanos Cancer Institute

Daniel George, MD

Professor of Medicine, Director of Genitourinary Oncology

Duke Cancer Institute

Lorelei Mucci, ScD, MPH

Professor of Epidemiology

Harvard TH Chan School of Public Health

Rana McKay, MD

Medical Oncologist, Assistant Professor of Medicine

University of California, San Diego

Jelani Zarif, PhD

Assistant Professor of Oncology

Johns Hopkins University

Camille Ragin, PhD, MPH

Associate Director, Diversity, Equity, and Inclusion

Fox Chase Cancer Center - Temple Health

Emily Rencsok

MD/PhD Candidate

Harvard T.H. Chan School of Public Health

Brandon A. Mahal, MD

Vice Chair of Academic Programs

University of Miami Health System, Miller School of Medicine

Kevin Kensler, ScD

Assistant Professor, Population Health Sciences

Weill Cornell Medical Center

Adam Friedantd, DO

Resident Neurologist

Einstein Healthcare Network

Travis Gerke

Director, Data Science

PCCTC

Natasha Roberts, PhD

Royal Brisbane and Women's Hospital

Brandon Holt

Clinical Trials Coordinator

Queensland University of Technology

Osarenren Ogbeide, MD

Medical Oncologist

Baptist Cancer Center

Ilkana Chowdury-Paulino

Doctoral Student

Harvard T.H. Chan School of Public Health

Clayton Yates, PhD

Professor of Pathology

Johns Hopkins University

Panagiotis Vlachostergios, MD, PhD

Clinical Assistant Professor of Medicine

Weill Cornell Medical Center

Brent Rose, MD

Radiation Oncologist

University of California, San Diego

Maria Jackson

Professor

University of the West Indies

Andre Fay, MD

Professor of Medicine

Pontifícia Universidade Católica do Rio Grande do Sul

Adriano Gonçalves e Silva

Medical Oncologist

Instituto do Câncer e Transplante de Curitiba (ICTR)

Gilian Wharfe, PhD

Professor

University of the West Indies

Kosj Yamoah, MD, PhD

Chair, Department of Radiation Oncology

Moffitt Cancer Center

Stacey Simmons, MD

Senior Medical Director Breast and Ovarian Cancer

Novartis

Biospecimen Working Group

Andre Fay, MD

Professor of Medicine

Pontifícia Universidade Católica do Rio Grande do Sul

Alex Wyatt, DPhil

Associate Professor in Urologic Sciences

Vancouver Prostate Centre

Ray McDermott

Medical Oncologist

Tallaght University Hospital

Carmen Swanepoel, PhD

Principal Medical Scientist

Stellenbosch University

Qaasim Dramat, MSc

Stellenbosch University

Joaquin Mateo, MD, PhD

Medical Oncologist

Vall d'Hebron Institute of Oncology

Teresa Casals

Laboratory Manager

Vall d'Hebron Institute of Oncology

Annica Lofgren

Research Nurse

Skane University Hospital

Simone Kaelin

Project Manager

Kantonsspital St. Gallen

Cheryl Gillett, PhD

Head of Tissue Banking, Health Schools

King’s Health Partners Cancer Biobank

Julia Stevenson, PhD, MSc

Senior Biobank Technician

King’s Health Partners Cancer Biobank

Pati Soule

Laboratory Manager

Harvard T.H. Chan School of Public Health

Philip Kantoff

M.D.

CEO and co-Founder, Convergent Therapeutics

Andrew Armstrong, MD

Medical Oncologist, Professor of Medicine

Duke University

Ian Davis

MBBS(Hons), Ph.D, FRACP, FAChPM, FAHMS, GAICD

Monash University

Rana McKay, MD

Medical Oncologist, Assistant Professor of Medicine

University of California, San Diego

Valerie Odero-Marah. PhD

RCMI Executive Director & Contact PI

Morgan State University

Kayode Adeniji

Pathologist

University of Ilorin

Haruna Nggada, MBBS

University of Maiduguri

Bernardo L. Rapoport, MD

Chief Medical Oncologist

Medical Oncology Centre of Rosebank

Anders Bjartell, M.D., Ph.D FEBU

Professor of Urology

Skane University Hospital

LMIC Working Group

Ademola Popoola, MBBS, FMCS, FWACS

Associate Professor of Urology Surgery, Consultant Urologist

University of Ilorin

Simone Badal, BSc., MPhil, MBA, PhD

Senior Lecturer, Anticancer Researcher

University of the West Indies - Mona Campus

Mario Jackson

Research Assistant

University of the West Indies - Mona Campus

Folakemi Odedina, PhD

Professor of Hematology/Oncology

Mayo Clinic Florida

Parisa Fathi

IRB Specialist

University of Central Florida

Nicole Fitzgibbon

Clinical Research Coordinator

Mayo Clinic Florida

Janaki Sharma, MD

Hematologist Oncologist

University of Miami Health System

Camille Ragin, PhD, MPH

Associate Director, Diversity, Equity, and Inclusion

Fox Chase Cancer Center

Sharon Harrison

Post Doctoral Associate

Fox Chase Cancer Center - Temple Health

Ruth Agaba Joseph

Operations Manager for CapTC Africa

University of Ilorin

Oluwaseyi (Seyi) Toye

Operations Manager for CaPTC Africa, National Coordinator

University of Ilorin

Natalie Greaves

Programme Coordinator, MPhil/PhD in Public Health and Epidemiology Chair-Faculty Entrepreneurship Committee

University of the West Indies - Cave Hill Campus

Simon Anderson

Director, George Alleyne Chronic Disease Research Centre

University of the West Indies - Cave Hill Campus

Opeyemi Bolajoko

Postdoctoral Research Fellow

Mayo Clinic Florida

Emily Rencsok

MD/PhD Candidate

Harvard T.H. Chan School of Public Health

Lorelei Mucci, ScD, MPH

Professor of Epidemiology

Harvard TH Chan School of Public Health

Andre Fay, MD

Professor of Medicine

Pontifícia Universidade Católica do Rio Grande do Sul